| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human TRIM47 recombinant protein (Position: A206-I624) was used as the immunogen for the TRIM47 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
TRIM47 Antibody / Tripartite motif-containing protein 47 is a anti-TRIM47 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), ELISA with listed reactivity in Human, Mouse, Rat. Reported localization: Nuclear, cytoplasmic.
Key elements and design rationale
- Target: TRIM47
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, IHC, ICC/IF, ELISA
Biological background
Functionally, TRIM47 antibody identifies a 638-amino-acid cytoplasmic and nuclear protein that facilitates ubiquitination of target substrates, marking them for proteasomal degradation or functional modification. TRIM47 modulates diverse cellular pathways, including interferon signaling, MAPK activation, and cell cycle regulation. Its ligase activity controls turnover of key signaling mediators, contributing to immune homeostasis and stress response.
The TRIM47 gene is located on chromosome 17q24.3 and is expressed in multiple tissues, including brain, kidney, and endothelial cells. TRIM47 interacts with adaptor proteins and kinases to regulate NF-kappaB activation, antiviral defense, and inflammatory signaling. It has also been implicated in the regulation of apoptosis and autophagy, linking ubiquitin signaling to cellular stress adaptation. TRIM47 may influence the degradation of misfolded or damaged proteins during oxidative or inflammatory stress.
In cancer biology, TRIM47 acts as an oncogenic factor in glioma, lung adenocarcinoma, and prostate cancer, where it promotes proliferation and metastasis by modulating MAPK and STAT3 pathways. Overexpression correlates with poor prognosis and enhanced resistance to apoptosis. Conversely, loss of TRIM47 activity may impair innate immune signaling, reducing antiviral defenses and inflammatory gene activation.
TRIM47 antibody is widely used in studies of ubiquitin signaling, innate immunity, and cancer biology. It is suitable for western blotting, immunoprecipitation, and immunofluorescence to examine TRIM47 expression and interactions. In immunology, this antibody supports investigations of antiviral pathways and cytokine regulation. In oncology, TRIM47 serves as a potential biomarker of tumor aggressiveness and therapeutic resistance.
Structurally, TRIM47 contains a RING-type zinc-binding motif conferring E3 ligase activity, B-box domains for stability, and a coiled-coil region for multimerization. Its C-terminal PRY/SPRY domain mediates substrate recognition and specificity.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Immunohistochemistry: map target signal in tissue context and compare regions/phenotypes.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
